Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Prospective Study Comparing Three Regimens Of Eloxatin ™ Plus Fluoropyrimidine For Evaluation Of Safety And Tolerability In First Line Treatment Of Patients With Advanced Colorectal Cancer (Tree Study)

NCT00062426 is registered in ClinicalTrials.gov with Prologue Research International as lead sponsor.

NCT NCT00062426
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00062426 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Prospective Study Comparing Three Regimens Of Eloxatin ™ Plus Fluoropyrimidine For Evaluation Of Safety And Tolerability In First Line Treatment Of Patients With Advanced Colorectal Cancer (Tree Study)
Lead sponsor
Prologue Research International
Phase
Phase 3
Overall status
Completed
Start date
May 31, 2003
Completion date
February 28, 2011
Enrollment
Not reported
Sites
52

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer